-transparent.png){kind=logo}
Several authors have reported reduced levels of pro-opiomelanocortin (POMC)-related peptides in the cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD), but the mechanisms regulating the CSF content of these substances are still debated. In this case report the processing of POMC peptides has been investigated post-mortem (HPLC and RIA methods) at the pituitary and hypothalamic level in an AD patient and in a control subject. From the results obtained it seems likely that defects of axonal transport and/or secretion rather than synthesis could account for the abnormalities of POMC peptides in the CSF.
Related Publications
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
June 1989,
The International journal of neuroscience,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
May 2004,
Journal of thrombosis and haemostasis : JTH,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
January 1991,
Cell biophysics,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
June 2008,
Journal of neuroendocrinology,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
February 1989,
The American journal of physiology,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
October 1991,
European journal of biochemistry,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
April 1989,
Journal of neurochemistry,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
January 1983,
Life sciences,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
June 1989,
Nature,
F Facchinetti, and
A R Storchi, and
C Pacchetti, and
E Martignoni, and
A R Genazzani
September 1997,
Journal of neuroimmunology,
